Reproductive Health News

The FDA announced it has commissioned an independent literature review and internal bench laboratory study to evaluate metals in tampons after a recent study suggested tampons sold in the U.S. tested for the presence of toxic metals.

Women with asthma required more fertility treatments and experienced more fetal loss in Denmark, according to an abstract presented at the European Respiratory Society International Congress.

Women with vs. without disabilities have higher severe maternal morbidity risk during childbirth, with the highest risks observed for women with vision or physical disabilities, researchers reported in O&G Open.

Extending routine donor-recipient matching to include Rhesus c, E and K antigens was tied to lower odds for hemolytic disease of the fetus and newborn vs. standard ABO blood type and Rhesus D antigen matching, researchers reported.

Fish oil supplementation during pregnancy was associated with children having a lower or higher risk for developing atopic dermatitis depending on the mother’s genotype, according to a study.

To improve morbidity and mortality rates for postpartum Black women, clinicians must focus on patients’ lived experiences, communication needs and the consequences of structural racism, researchers reported in O&G Open.

Women with fetal overgrowth or hypertensive disorders of pregnancy have notable continuous glucose monitor-derived glycemic patterns detected during early pregnancy, sometimes without a gestational diabetes diagnosis, researchers reported.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Shivani Kamat, MD, of UT Southwestern Medical Center in Texas, shares her experiences with in vitro fertilization as a woman in medicine.

At-home first-dose misoprostol administration increased the proportion of women completing medical abortion after 12 weeks’ gestation through outpatient care with a favorable safety profile, according to findings published in The Lancet.

Obstetric outcomes for gestational carriers were similar to non-surrogate pregnancies using fertility treatments, with both groups having higher odds for hypertensive disorders of pregnancy vs. general pregnancies, data show.